{"url_path":"/sec/lpcn/8-k/2026-06-04/item-8-01","section_key":"item-8-01","section_title":"Item 8.01 **","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-04","source_url":"https://www.sec.gov/Archives/edgar/data/1535955/0001493152-26-027209-index.html","accession_number":"0001493152-26-027209","cik":"0001535955","ticker":"LPCN","issuer_name":"Lipocine Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1535955/0001493152-26-027209-index.html","primary_entity_key":"0001535955","primary_entity_name":"Lipocine Inc."},"word_count":62,"has_tables":true,"body_markdown":"**Item\n8.01**\n**Other\nEvents**\n\n \n\nOn\nJune 4, 2026, the Company issued a press release announcing Lipocine will be hosting a virtual KOL event highlighting unmet needs in\npostpartum depression and the clinical profile of LPCN 1154 on Friday, June 12, 2026, at 11:00 AM Eastern Time. The press release is\nfurnished as Exhibit 99.1 to this report and incorporated by reference herein."}